Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease

被引：0
|
作者：
Gao, Xiaoya [1 ,2 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Pediat Neurol, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
来源：
FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 15卷
关键词：
Alzheimer's disease; Parkinson's disease; disease modification; neuroprotection; novel targets; neurodegeneration;
D O I：
10.3389/fnagi.2023.1247256
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Alzheimer's failure raises questions about disease-modifying strategies
    Andy Extance
    Nature Reviews Drug Discovery, 2010, 9 : 749 - 751
  • [42] Alzheimer's failure raises questions about disease-modifying strategies
    Extance, Andy
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (10) : 749 - U87
  • [43] Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
    Ettcheto, Miren
    Busquets, Oriol
    Camins, Antoni
    NEURAL REGENERATION RESEARCH, 2019, 14 (10) : 1721 - 1725
  • [44] Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
    Miren Ettcheto
    Oriol Busquets
    Antoni Camins
    Neural Regeneration Research, 2019, 14 (10) : 1721 - 1725
  • [45] New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
    Lorente-Picon, Marina
    Laguna, Ariadna
    BIOMOLECULES, 2021, 11 (03) : 1 - 39
  • [46] Translating scientific advances into disease-modifying therapies for Parkinson's Disease
    Cenci, M. Angela
    Olanow, C. Warren
    EXPERIMENTAL NEUROLOGY, 2017, 298 : 135 - 136
  • [47] Enhancement of glycolysis: A potential disease-modifying strategy for Parkinson's disease
    Morales-Briceno, Hugo
    Fung, Victor S. C.
    MOVEMENT DISORDERS, 2020, 35 (01) : 81 - 81
  • [48] Does Rasagiline Have a Disease-Modifying Effect on Parkinson’s Disease?
    Shyamal H. Mehta
    John C. Morgan
    Kapil D. Sethi
    Current Neurology and Neuroscience Reports, 2010, 10 (6) : 413 - 416
  • [49] α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease
    Cole, Tracy A.
    Zhao, Hien
    Collier, Timothy J.
    Sandoval, Ivette
    Sortwell, Caryl E.
    Steece-Collier, Kathy
    Daley, Brian F.
    Booms, Alix
    Lipton, Jack
    Welch, Mackenzie
    Berman, Melissa
    Jandreski, Luke
    Graham, Danielle
    Weihofen, Andreas
    Celano, Stephanie
    Schulz, Emily
    Cole-Strauss, Allyson
    Luna, Esteban
    Quach, Duc
    Mohan, Apoorva
    Bennett, C. Frank
    Swayze, Eric E.
    Kordasiewicz, Holly B.
    Luk, Kelvin C.
    Paumier, Katrina L.
    JCI INSIGHT, 2021, 6 (05)
  • [50] CDNF: An innovative actor in disease-modifying approaches for Parkinson's disease
    Tenenbaum, Liliane
    MOLECULAR THERAPY, 2021, 29 (09) : 2634 - 2636
12345